159711 Reed Report 55-102 7 3 06 12:04 Page 71 Reed Elsevier Annual Reports and Financial Statements 2005 71 4 Pension schemes continued As at 31 December 2005 the net cumulative actuarial losses recognised in the statement of recognised income and expense, since transition to IFRS effective from 1 January 2004 was 111m a163m, comprising: 2005 2004 2005 2004 m m gm am Experience losses on scheme liabilities 25 18 37 26 Experience gains on scheme assets 230 66 336 97 Actuarial losses arising on the present value of scheme liabilities due to changes in: discount rates 217 113 317 166 other actuarial assumptions 25 9 36 14 Total actuarial losses charged directly to equity 37 74 54 109 The combined businesses expect to contribute approximately 70m a102m to their defined benefit pension schemes in 2006.
5 Share based remuneration Reed Elsevier offers a number of share based remuneration schemes to directors and employees.
The principal share based remuneration schemes comprise share options, under the Executive Share Option Schemes ESOS and the Long Term Incentive Scheme LTIS, and conditional shares under LTIS, the Retention Share Plan RSP and the Bonus Investment Plan BIP, in relation to Reed Elsevier PLC and Reed Elsevier NV ordinary shares.
Share options granted under ESOS and LTIS are exercisable after three years and up to ten years from the date of grant at a price equivalent to the market value of the respective shares at the date of grant.
Conditional shares granted under LTIS, RSP and BIP are exercisable after three years for nil consideration.
All share based remuneration awards are subject to the condition that the employee remains in employment at the time of exercise.
Share options and conditional shares granted under LTIS, RSP, certain ESOS and BIP are further subject to the achievement of growth targets of Reed Elsevier PLC and Reed Elsevier NV adjusted earnings per share measured at constant exchange rates.
The estimated fair value of grants made in the year ended 31 December 2005 and in the prior year, and the main assumptions used, which have been established with advice from and data provided by independent actuaries, are set out below.
The fair value of grants made in any year is recognised in the income statement over the vesting period, typically 3 years.
In respect of In respect of Reed Elsevier PLC ordinary shares Reed Elsevier NV ordinary shares Total fair value Weighted Weighted average fair average fair Number of value Number of value shares per award Fair value shares per award Fair value 2005 grants 000 m 000 ggmm gm Share options 11,520 1.05 12 7,471 g1.91 14 22 32 Conditional shares 951 4.87 5 406 g10.27 4 8 11 Total 17 18 30 43 159711 Reed Report 55-102 7 3 06 12:04 Page 72 72 Combined financial statements Notes to the combined financial statements For the year ended 31 December 2005 5 Share based remuneration continued In respect of In respect of Reed Elsevier PLC ordinary shares Reed Elsevier NV ordinary shares Total fair value Weighted Weighted average fair average fair Number of value Number of value shares per award Fair value shares per award Fair value 2004 grants 000 m 000 aamm am Share options 22,532 1.35 30 15,235 a2.63 40 57 84 Conditional shares 5,141 4.59 24 3,391 a9.96 34 47 69 Total 54 74 104 153 In respect of In respect of Reed Elsevier PLC Reed Elsevier NV ordinary shares ordinary shares Assumptions for grants made during the year 2005 2004 2005 2004 Share options Weighted average share price at date of grant 5.24 4.86 g11.30 a10.57 Expected volatility 22% 32% 22% 32% Expected option life 4 years 4 years 4 years 4 years Expected dividend yield 2.6% 2.0% 2.6% 2.0% Risk free interest rate 5.1% 5.1% 3.4% 3.4% Expected lapse rate 3-5% 3-5% 3-5% 3-5% Conditional shares Weighted average share price at date of grant 5.26 4.87 g11.05 a10.57 Expected dividend yield 2.6% 2.0% 2.6% 2.0% Risk free interest rate 5.1% 5.1% 3.4% 3.4% Expected lapse rate 3% 3% 3% 3% Expected volatility has been estimated based on relevant historic data in respect of the Reed Elsevier PLC and Reed Elsevier NV ordinary share prices.
The share based remuneration awards outstanding as at 31 December 2005, in respect of both Reed Elsevier PLC and Reed Elsevier NV ordinary shares, are set out below.
In respect of Reed Elsevier PLC ordinary shares In respect of Reed Elsevier NV ordinary shares 2005 2004 2005 2004 Weighted Weighted Weighted Weighted 2005 average 2004 average 2005 average 2004 average Number of exercise Number of exercise Number of exercise Number of exercise shares price shares price shares price shares price Share options '000 pence '000 pence '000 g '000 a Outstanding at start of year 63,655 500p 63,780 501p 42,103 g11.30 41,966 a11.67 Granted 11,520 524p 22,532 482p 7,471 g11.30 15,235 a10.57 Exercised 3,629 426p 2,913 428p 1,892 g10.37 1,377 a10.19 Forfeited 4,915 519p 19,446 494p 2,812 g11.85 13,448 a11.65 Expired 92 439p 298 494p 111 g10.16 273 a17.07 Outstanding at end of year 66,539 507p 63,655 500p 44,759 g11.30 42,103 a11.30 Exercisable at end of year 22,747 552p 19,660 525p 16,557 g12.81 13,873 a12.37 The weighted average share price at the date of exercise of share options during 2005 was 533p 2004: 513p for Reed Elsevier PLC ordinary shares and a11.31 2004: a11.31 for Reed Elsevier NV ordinary shares.
Conditional shares will be met from shares held by the EBT.
